Clinical Trials Sponsored by Stiftung IHF - Institut für Herzinfarktforschung

Total 128 results

Institut für Klinische Krebsforschung IKF GmbH...
Trium Analysis Online GmbH; mca Berlin

Completed

Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program (QoliXane)

Metastatic Pancreatic Cancer

Germany
Institut für Klinische Krebsforschung IKF GmbH...
AstraZeneca; Universitätsklinikum Köln, Germany; Universitätsklinikum Düsseldorf...

Not yet recruiting

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

Extrahepatic Cholangiocarcinoma | Unresectable Perihilar or Ductal CCA

Germany
North Eastern German Society of Gynaecological...
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Not yet recruiting

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy (N-Plus)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Clear Cell Carcinoma
University Medicine Greifswald
Bristol-Myers Squibb; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus... and other collaborators

Completed

Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas (NiTraSarc)

Metastatic Adult Soft Tissue Sarcoma

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Organon Healthcare GmbH

Active, not recruiting

Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma

Esophagogastric Adenocarcinoma

Germany
Universitätsmedizin Mannheim
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche...

Active, not recruiting

Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

Gastroesophageal Junction Adenocarcinoma

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Eli Lilly and Company; Trium Analysis Online GmbH

Active, not recruiting

RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients (RAMTAS)

Colorectal Cancer

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Eli Lilly and Company; Trium Analysis Online GmbH

Completed

Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy (RAMOS)

Squamous Cell Carcinoma of the Esophagus

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Johann Wolfgang Goethe University Hospital, Prof. Dr. med. Trojan

Active, not recruiting

Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

Hepatocellular Carcinoma (HCC) | Second Line Treatment

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Celgene International II S.á.r.l.; Prof. F. Heidel, MH Hannover

Recruiting

Fedratinib in Combination With Nivolumab

Primary Myelofibrosis | Secondary Myelofibrosis

Germany
Nikolaj Frost MD
Roche Pharma AG; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...

Recruiting

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma (ANTELOPE)

Non-Small Cell Lung Cancer Metastatic

Germany
Dominik Paul Modest
German Research Foundation; Institut für Klinische Krebsforschung IKF GmbH...

Recruiting

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

Colorectal Cancer

Germany
North Eastern German Society of Gynaecological...
Clovis Oncology, Inc.; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...

Active, not recruiting

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients (MAMOC)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Clear Cell Carcinoma

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Sanofi; Trium Analysis Online GmbH; STABIL - Statistische und Biometrische Lösungen

Completed

Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer (ELDERLY)

Colorectal Cancer

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Medizinische Hochschule Hannover, Germany, Prof. Dr...

Active, not recruiting

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Hepatocellular Carcinoma

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...

Recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer (TRAP-BTC)

Biliary Tract Cancer | HER2 Gene Mutation

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Charite University, Berlin, Germany; Roche Pharma AG; Hoffmann-La Roche; Arbeitsgemeinschaft... and other collaborators

Recruiting

Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP (R-Pola-Glo)

Lymphoma, Large B-Cell, Diffuse

Germany, Austria
Ralf Hofheinz
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche... and other collaborators

Recruiting

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Rectal Cancer

Germany
Norwegian Institute of Public Health
International Centre for Diarrhoeal Disease Research, Bangladesh; Sykehuset...

Completed

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

Hepatitis E Infection

Bangladesh
Clinical Centre of Serbia
Axonic; SensArs Neuroprosthetics Sarl; Institut für Mikrosystemtechnik (IMTEK)... and other collaborators

Completed

Prosthesis With Sensations

Amputation | Phantom Limb Pain | Sensory Deficit

Serbia
Centre For International Health
Sykehuset Innlandet HF; Tribhuvan University Teaching Hospital, Institute Of... and other collaborators

Active, not recruiting

Vitamin B12 Supplementation During Pregnancy on Cognitive Development (VitaPreg)

Anemia | Pregnancy Related | Vitamin B 12 Deficiency

Nepal
Boston University Charles River Campus
Boston University; Health Resources and Services Administration (HRSA); Institute... and other collaborators

Unknown

Growing Together: Women in Opioid Treatment and Their Infants

Substance-Related Disorders

United States
Amsterdam UMC, location VUmc
Netherlands Brain Foundation; GGZ inGeest; International Parkinson Foundation... and other collaborators

Completed

Effect of Bright Light on Mood and Sleep in Parkinson's Disease (LightPD)

Depression | Parkinson's Disease

Netherlands
Australasian Gastro-Intestinal Trials Group
Bristol-Myers Squibb; Bayer; Syneos Health; University of Sydney; National Cancer... and other collaborators

Active, not recruiting

RegoNivo vs Standard of Care Chemotherapy in AGOC (INTEGRATEIIb)

Gastro-Oesophageal Cancer

Korea, Republic of, Australia, Taiwan, United States, Germany, Japan, Spain, Italy, Austria
Paris Translational Research Center for Organ Transplantation
Agence de La Biomédecine; Eurotransplant; United Network for Organ Sharing; Deutsche... and other collaborators

Unknown

COVID-19 Pandemic and Worldwide Organ Procurement (COVID)

COVID-19

France
Sykehuset Innlandet HF
King's College London; Karolinska Institutet; Oslo University Hospital; University... and other collaborators

Active, not recruiting

Resource Use and Disease Course in Dementia (REDIC) (REDIC)

Neurodegenerative Diseases | Dementia

Norway
Fondazione IRCCS Istituto Nazionale dei Tumori,...
The Leeds Teaching Hospitals NHS Trust; University of Leeds; European Organisation... and other collaborators

Not yet recruiting

Validation of the European Oncology Quality of Life Toolkit

Cancer | Palliative Care | Survivorship

Hungary, Italy, France, United Kingdom, Netherlands, Estonia, Serbia, Lithuania, Slovenia, Albania, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Finland, Georgia, Germany, Greece, Ireland, Latvia, Moldova, Republic of, Norwa... and more
Hospital Universitari Vall d'Hebron Research Institute
UMC Utrecht; University of Rome Tor Vergata; Queen's University, Belfast; University... and other collaborators

Active, not recruiting

Retinal and Cognitive Dysfunction in Type 2 Diabetes (RECOGNISED)

Cognitive Dysfunction | Retinal Function | Microperimetry

Spain

Clinical Trials Sponsored by Stiftung IHF - Institut für Herzinfarktforschung

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations